Gemcitabine Hydrochloride

Gemcitabine Hydrochloride

5.2 Moderate risk

Gemcitabine Hydrochloride & Myelosuppression

9.8%

of users reported Myelosuppression

68.3%

also reported Severe reaction

59.3%

are women

Most common medical consequences

Severe reaction
68.3%
Hospitalization
20.6%
Life-threatening condition
11.1%

Have you experienced any negative side effects from this medication?

Gemcitabine Hydrochloride: general information

Most common side effects (30)

Most commonly affected ages

10 - 19 years
3.5%
20 - 29 years
<0.1%
30 - 39 years
<0.1%
40 - 49 years
7.0%
50 - 59 years
20.8%
60 - 69 years
30.8%
70 - 79 years
30.9%
80 - 89 years
7.0%